Healthy eLifestyle Program (HeLP) Clinical Trial Results: Western International Review Board (IRB) Clinical Study under FDA Guidelines

This 12-week clinical trial involved 25 participants who:

• lost an average of 13 pounds
• Decreased waist measurement an average of 2 ½ inches, which is evidence of central weight loss.
• Decreased total cholesterol an average of 17%,
• Decreased LDL cholesterol an average of 21%,
• Decreased triglyceride levels an average of 31%.
• HDL cholesterol remained unchanged but it has been my clinical experience that it takes 9 to 12 months on this program to see significant improvements in the good or HDL cholesterol.
• Decreased blood pressure (both diastolic and systolic) an average of 8%.
• Increased their insulin sensitivity index an average of 11%.

In other words, the clinical improvements that were noted in this clinical trial were directly related to improvement in insulin sensitivity. Since HeLP is a 15-month program, this clinical study on weight loss and clinical improvements continue to improve.

Supporting Research

• Insulin Resistance Studies
• Insulin Resistance and Risk of Congestive Heart Failure
• Insulin Secretion In The Diagnosis Of Adult-Onset Diabetes Mellitus
• The Effects of a Low Glycemic Diet and Supplements on Insulin Resistance
• Clinical Study under FDA guidelines of the Healthy eLifestyle Program
• Nutritional Supplement (Cellular Nutrition)
• Optimal Diets for Prevention
• Dietary Fiber, Glycemic Load
• Diet and Physical Activity Behaviors
• Lifestyle Modification
• The Obesity Epidemic
• Walking Compared With Vigorous Physical Activity
• Intensity and Amount of Physical Activity
• Television Watching
• Effects of Internet Behavioral Counseling
• Effect of Weight Loss and Lifestyle Changes
• Detection, Evaluation, and a Treatment of High Blood Pressure
• References
• Metabolic Acid-Base Balance
• Essential Fatty Acids Fish Oil (Omega 3 Fatty Acids)
• Seventh JNC Report